Second autologous transplantation after failure of a first autologous transplant in 18 patients with non-Hodgkin's lymphoma.
Lenain
Christelle
C
Department of Haematology, Centre Léon Bérard, Lyon, France.
Dumontet
Charles
C
Gargi
Therese
T
Chassagne
Catherine
C
Berger
Francoise
F
Perol
David
D
Garnier
Maud
M
Coiffier
Bertrand
B
Blay
Jean Yves
JY
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000401:mortality / Q000706:statistics & numerical data*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual; D009503:Neutropenia / Q000209:etiology; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects / Q000401:mortality / Q000706:statistics & numerical data*; D011658:Pulmonary Fibrosis / Q000209:etiology / Q000401:mortality; D019233:Retreatment / Q000009:adverse effects / Q000706:statistics & numerical data; D012189:Retrospective Studies; D000069283:Rituximab; D016879:Salvage Therapy / Q000009:adverse effects / Q000401:mortality / Q000706:statistics & numerical data*; D018805:Sepsis / Q000209:etiology / Q000401:mortality; D016019:Survival Analysis; D014182:Transplantation, Autologous / Q000706:statistics & numerical data*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab